English Misonix Has Been Acquired by Bioventus On October 29, 2021, Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced the acquisition of Misonix, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. The current Misonix product offerings are state-of-the-art technologies that are supported by next generation products in the pipeline and this agreement will allow those to scale and reach their full potential. To learn more about Misonix and Misonix’s product offerings, click on one of the links below. Interested in Misonix careers. Click here for current job postings. About Bioventus Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and surgical solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. ©2021 Bioventus. All rights reserved. Privacy Policy | Terms of Use | Copyright & Disclaimer ABOUT US PRODUCTS PATIENTS PHYSICIANS PAYERS NEWS CAREERS INVESTORS CONTACT US BIONET Bioventus adheres to the AdvaMed Code of Ethics Bioventus, the Bioventus logo, DUROLANE and EXOGEN are registered trademark of Bioventus LLC. GELSYN-3 is a trademark of Bioventus LLC. SUPARTZ FX is a registered trademark of Seikagaku Corp. All other trade names referenced are the trademarks or registered trademarks of their respective companies.

Youtube Linkedin Instagram Twitter Facebook Open Positions at Misonix Careers References Copyright 2021 Misonix Privacy Policy This site uses cookies and other web tracking technologies. By continuing on this site you agree to the use of these cookies. Please click here to view our Cookie Policy and manage the cookies we use. OkPrivacy policy